Marked Chart Marked Chart Closed

The Marked Chart Wire · Health

Johnson & Johnson

Johnson & Johnson reports lower mortality with Impella heart pumps

Johnson & Johnson says its Impella heart pumps are linked to lower mortality rates in patients. The company released the clinical data on Friday.

JNJ-0.7%

Illustration for the Health desk

The stocks in this story

  1. JNJ-0.7%Johnson & Johnson$273.20

Prices from Based on Fri, Oct 30 close · Opens Mon 9:30 AM ET. Each tile opens the stock's chart and news.

New to this? Read: Reading a stock chart

More Health news

Fast headlines, summarized. Not verified and not advice. Check the full story before you act.